Front Page News
Great Progress, Greater Need
In the last few years, we’ve gotten closer to an approved treatment than we ever have been. Through research funded by Cure SMA, we’ve identified […]
5th Annual South Florida Gala of Hope Raises Record Total of $224,000
The 5th Annual South Florida Chapter Gala of Hope was a fantastic evening to raise funds and awareness of SMA. This year’s event has already […]
5th Annual Hope on the Hill Congressional Dinner Advances SMA Advocacy
This year’s 5th Annual “Hope on the Hill” Congressional Dinner will be held on Tuesday, December 1, bringing together families, government, and industry for an […]
Clinical and Regulatory Webinar and Extended Q&A Now Available
A recording of last week’s Cure SMA Clinical and Regulatory Webinar is now available online. WATCH Our thanks again to our three panelists—Dr. Tim Franson, […]
Fall 2015 Issue of Compass Highlights SMA Researcher Meeting
The latest issue of Compass, our research publication, is now available online. This fall 2015 issue covers our 2015 SMA Researcher Meeting. The researcher meeting […]
Cure SMA Medical Advisory Council Meets in Chicago
Members of Cure SMA’s Medical Advisory Council (MAC) have gathered in Chicago for two days of meetings to set the agenda for the care of […]
Tell Your Senator to Support Innovations for Healthier Americans
We need your help in contacting your Senators to tell them that legislation promoting innovation and research is extremely important to you and that the […]
Cure SMA Welcomes the North Jersey Chapter
Cure SMA is pleased to announce the creation of a new chapter in northern New Jersey, serving families and supporters with zip codes starting with […]
Cure SMA and Other Venture Philanthropy Leaders Share Insight at Partnering for Cures Panel
Cure SMA President Kenneth Hobby was a featured panelist at Partnering for Cures, a conference convened by the Milken Institute’s FasterCures initiative. At the event, […]
Cytokinetics Announces New Details on Upcoming Phase 2 Trial
Cytokinetics, in collaboration with Astellas, has announced further details about a planned Phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy (SMA). […]